FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized controlled trial in intermediate-risk NMIBC. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback